Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Says It Is Changing Its Cybersecurity Culture, And Others Should Too

This article was originally published in The Gray Sheet

Executive Summary

Speaking at the 2015 mHealth Summit, Suzanne Schwartz, the FDA device center's top cybersecurity expert, said the agency is undergoing a cultural shift to better deal with device cybersecurity vulnerabilities and urged manufacturers, security researchers and hospitals to do the same.

You may also be interested in...

Shuren To Industry: 'Hire A Hacker'

Companies say cybersecurity threats keep many CEOs awake at night. CDRH Director Jeff Shuren urge them to consider hiring hackers to conduct penetration testing of their medical devices and help ensure stronger security on their products.

Medical Device Hackers Now Deemed Allies By FDA, Industry

FDA and industry has changed their approach to hackers, and the hacking community has taken notice. As medical devices increasingly become connected, hackers want to be a part of efforts to improve their cybersecurity and FDA says it aims to make that happen. Also: a Gray Sheet podcast interview with Katie Moussouris, chief policy officer with the San Francisco-based cybersecurity company HackerOne.

EU Trails FDA In Device Cybersecurity Guidance, But Harmonization Anticipated

Story and podcast: Even though US regulators have provided more specific guidance on medical device cybersecurity requirements, European Union policy-makers appear to be on the same page, experts tell The Gray Sheet.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts